Tri-sprintec Kit
Product Images NDC 0555-9018

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tri-sprintec (NDC 0555-9018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Tri-Sprintec kit for a 28-day cycle containing norgestimate and ethinyl estradiol tablets. The pack shows a weekly layout with four rows labeled Start, Week 2, Week 3, and Week 4, each containing seven pills organized by day of the week. Pills are color coded in three different shades with instructions to take all colored pills before any white pills. Storage information and labeler Teva Pharmaceuticals USA, Inc. are visible.*

FDA Label Image

Image 2

A forest plot showing effect estimates (odds ratios/risk ratios) with confidence intervals from multiple cohort studies, including the NICHD Women's Contraceptive Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The x-axis is labeled 'Effect Estimate (OR/RR)' ranging approximately from -1.5 to 2.0.*

FDA Label Image

Image 3

Chemical structure diagram of norgestimate, USP, showing its molecular structure with labeled atoms and bonds.*

FDA Label Image

Image 4

Chemical structure of ethinyl estradiol as labeled in the image, showing the molecular arrangement including hydroxyl groups and a terminal alkyne group on the steroid backbone.*

FDA Label Image

Image 5

A vertical chart illustrating pregnancy rates per 100 women in one year, with methods of birth control categorized according to effectiveness. The scale ranges from fewer to more pregnancies, listing highly effective methods like implants and birth control pills at the top, and less effective methods like withdrawal and no birth control towards the bottom.*

FDA Label Image

Image 6

Tri-Sprintec (norgestimate and ethinyl estradiol) tablet blister pack for a 28-day dosing cycle. The pill pack is organized in four rows labeled Week 1 to Week 4 and seven columns representing days Sunday through Saturday. Pills are shaded in three colors across the rows, with the first row across seven days shaded light gray, the second row white, the third row dark gray, and the last row white. The label includes instructions to take all colored pills before white pills and storage information (20 to 25°C). The labeler is Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Image 7

Packaging label for Tri-Sprintec (norgestimate and ethinyl estradiol) tablets USP, a prescription drug kit manufactured by Teva Pharmaceuticals USA, Inc. The label features a yellow and white striped background with text indicating 6 blister cards of 28 tablets each, a 28-day supply, storage instructions, and patient information details. The Teva logo and a slogan 'Shaping Women's Health' are also visible.*

FDA Label Image

Image 8

Tri-Sprintec (norgestimate and ethinyl estradiol tablets USP) 28 Day Kit packaging label. The label features the product name, active ingredients, and dosage form. It includes information about 6 blister cards with 28 tablets each. The labeler is Teva Pharmaceuticals USA, Inc. The packaging has yellow and white vertical stripes with Teva's logo and a Shaping Women's Health logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.